An Evaluation of Drug-Ineffective Postmarketing Reports in Drug Safety Surveillance

被引：0
|
作者：
Misu, Takashi [1 ,2 ]
Kortepeter, Cindy [1 ]
Munoz, Monica [1 ]
Wu, Eileen [1 ]
Chung, Haemy [3 ]
Dal Pan, Gerald J. [1 ]
机构：
[1] US FDA, Silver Spring, MD USA
[2] Pharmaceut & Med Devices Agcy, Tokyo, Japan
[3] Univ Texas Austin, Coll Pharm, Austin, TX 78712 USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2017年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
537
引用
收藏
页码：324 / 324
页数：1
相关论文
共 50 条
  • [1] An Evaluation of “Drug Ineffective” Postmarketing Reports in Drug Safety Surveillance
    Misu T.
    Kortepeter C.M.
    Muñoz M.A.
    Wu E.
    Dal Pan G.J.
    [J]. Drugs - Real World Outcomes, 2018, 5 (2) : 91 - 99
  • [2] Postmarketing surveillance for drug safety
    Holden, WL
    Scarazzini, LJ
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2004, 76 (05) : 503 - 503
  • [3] An Evaluation of Postmarketing Reports from Industry-Sponsored Programs in Drug Safety Surveillance
    Harinstein, L.
    Kalra, D.
    Kortepeter, C.
    Munoz, M.
    Wu, E.
    Dal Pan, G.
    [J]. DRUG SAFETY, 2018, 41 (11) : 1206 - 1206
  • [4] Evaluation of Postmarketing Reports from Industry-Sponsored Programs in Drug Safety Surveillance
    Harinstein, Lisa
    Kalra, Dipti
    Kortepeter, Cindy M.
    Munoz, Monica A.
    Wu, Eileen
    Dal Pan, Gerald J.
    [J]. DRUG SAFETY, 2019, 42 (05) : 649 - 655
  • [5] Evaluation of Postmarketing Reports from Industry-Sponsored Programs in Drug Safety Surveillance
    Lisa Harinstein
    Dipti Kalra
    Cindy M. Kortepeter
    Monica A. Muñoz
    Eileen Wu
    Gerald J. Dal Pan
    [J]. Drug Safety, 2019, 42 : 649 - 655
  • [6] Postmarketing surveillance for drug safety - Reply
    Griffin, MR
    Stein, CM
    Ray, WA
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2004, 76 (05) : 504 - 505
  • [7] POSTMARKETING DRUG SURVEILLANCE
    BORDEN, EK
    GARDNER, JS
    WESTLAND, MM
    GARDNER, SD
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1984, 251 (06): : 729 - 729
  • [8] POSTMARKETING DRUG SURVEILLANCE
    FELDMANN, EG
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1979, 68 (12) : R1 - R1
  • [9] US FDA enhancing postmarketing drug safety surveillance
    [J]. Reactions Weekly, 2019, 1780 (1) : 3 - 3
  • [10] US FDA Enhancing Postmarketing Drug Safety Surveillance
    不详
    [J]. PHARMACEUTICAL MEDICINE, 2020, 34 (01) : 64 - 64
12345